Terumo India signs MoU with AIG Hospitals to strengthen interventional radiology training and improve patient outcomes across India

Corporate
Terumo India signs MoU with AIG Hospitals

Gurugram, 22 April 2026: In a significant step towards strengthening patient care in minimally invasive therapies, Terumo India the Indian arm of global medical technology leader Terumo Corporation (TSE: 4543), has signed a Memorandum of Understanding (MoU) with AIG Hospitals to establish a Centre of Excellence for Interventional Radiology (IR) under its flagship 'Elevate IR' programme.

This collaboration is designed with a clear patient-centric objective, i.e., to improve clinical outcomes, reduce procedural risks, and expand access to advanced, minimally invasive treatments for a wide range of conditions, from vascular diseases and cancers to life-threatening emergencies.

As part of the initiative, AIG Hospitals will serve as the first training centre, offering a structured and immersive learning pathway for interventional radiologists. The programme integrates simulation-based training, expert-led sessions, and case-based discussions, supported by the Terumo India Skill Lab (TISL), an advanced training facility focused on enhancing real-world procedural skills.

Speaking on the partnership, Mr. Shishir Agarwal, President and Managing Director, Terumo India, said, "We have always believed that better patient outcomes begin with how well clinicians are trained and supported. Our collaboration with AIG Hospitals reflects a shared commitment to advancing clinical capabilities through structured, hands-on learning. Through this initiative, we aim to strengthen the Interventional Radiology ecosystem and enable young IRs to deliver better patient outcomes at scale."

Speaking on the occasion Dr. D Nageshwar Reddy, Chairman, AIG Hospitals said "India today stands at a critical intersection where the burden of chronic diseases is rising sharply, while the expectations from healthcare are shifting towards safer, faster, and more patient-friendly solutions. Interventional Radiology represents this shift, moving us away from invasive surgeries to precise, image-guided therapies that significantly improve recovery and quality of life. However, the true potential of these advancements can only be realized when we invest in building a highly skilled ecosystem of clinicians. Structured training initiatives like this are not just about advancing medical expertise; they are about ensuring that every patient, regardless of geography, has access to the highest standards of care."

The programme leverages cutting-edge simulation tools, including liver flow models and Mentice Virtual Simulators, allowing practitioners to rehearse complex procedures in a risk-free environment before performing them on patients. Dedicated modules on vascular closure techniques further ensure safer post-procedural outcomes.

Dr. Jagadeesh R Singh, Director – Interventional Radiology, AIG Hospitals further added, "The Centre of Excellence aims to address this critical need by introducing a standardized training framework that bridges the gap between foundational knowledge and real-world clinical practice. Interventional Radiologists will gain proficiency in essential and advanced procedural areas such as vascular access, microcatheter navigation, and aorto-iliac interventions."

By building a robust ecosystem for skill development, this collaboration between Terumo India and AIG Hospitals aims to democratize expertise in Interventional Radiology, ensuring that more patients, across geographies, can benefit from safer, faster, and more effective treatments.

More about Interventional Radiology:

Interventional Radiology has transformed modern medicine by enabling procedures that once required open surgery to now be performed through tiny incisions, guided by real-time imaging. This translates directly into tangible benefits for patients, shorter hospital stays, reduced pain, faster recovery, and significantly lower complication rates.

Today, several IR procedures are considered standard of care across specialties:

  • Angioplasty and stenting for peripheral arterial disease, helping restore blood flow and prevent limb loss
  • Embolization procedures for controlling internal bleeding, fibroids, and certain cancers
  • Image-guided tumor therapies such as chemoembolization for liver cancers
  • Dialysis access interventions to maintain life-saving vascular access for kidney patients
  • Minimally invasive interventions, where timely clot removal can be life-altering

However, the effectiveness of these procedures depends heavily on the operator's precision, decision-making, and ability to navigate complex vascular anatomy, skills that require rigorous, hands-on training beyond conventional classroom learning.

About AIG Hospitals

AIG Hospitals is one of World's leading institutions for advanced healthcare, research, and medical academics. Built on the legacy of the Asian Institute of Gastroenterology, the institution has evolved into a world-class multispecialty healthcare ecosystem committed to delivering accessible and equitable care. Founded under the leadership of Dr. D. Nageshwar Reddy, AIG Hospitals has been at the forefront of clinical excellence, innovation, and research in medicine. What began as a specialized centre for gastrointestinal care has grown into a multidisciplinary institution serving patients across more than 40 medical specialties. Today, AIG Hospitals operates across three units with 1400+ beds and over 350 ICU beds, supported by a team of 600+ highly skilled doctors and healthcare professionals. The brand is globally recognized for managing complex medical conditions with exceptional clinical outcomes while maintaining international standards of quality and patient safety. The institution is also home to the largest gastrointestinal endoscopy unit in the world, performing one of the highest volumes of advanced interventional procedures globally. AIG has pioneered several breakthroughs in the field, including the world's first transgastric appendectomy and innovations such as EUS-guided portal pressure measurement, continuing to push the boundaries of medical science.

For press queries, reach out to [email protected]

About Terumo India

Terumo India is a fast-growing medical devices company that serves to advance access to high-quality Cardiac & Vascular, and other medical devices for patients and medical practitioners in India. Terumo India is part of Terumo Corporation, a global leader in medical technology with headquarters in Tokyo, Japan. Established in 1921 and with its 100 years of history, Terumo's starting point and unchanging corporate mission has been 'Contributing to Society through Healthcare'.

Terumo India was established in 2013 with headquarters in Gurgaon, NCR Delhi and has since grown to touch over 100,000 lives with an expanding field force & distribution network. Terumo India is Great Place to Work® certified and has also been recognized as one of India's Top 15 Workplaces™ in Pharmaceuticals, Healthcare and Biotech 2022. The company runs several acclaimed training & development programs, working closely with its customers and academic partners to contribute to the skilling requirements of India's healthcare system.

Media Contact

Terumo India Private Limited

About Terumo

Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of "Contributing to Society through Healthcare." Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.

Media Contact

Corporate Communication Dept., Terumo Corporation

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.